In randomized managed trials, There's two treatment alternatives now deemed the typical of treatment in Guillain-Barré syndrome (GBS). These contain both intravenous immunoglobulin (IVIG) or plasma exchange. IVIG is https://ksnr.org.in/guillain-barre-syndrome/